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1. INTRODUCTION 
Recent data in rats with mosapride and in mice 
with prucalopride, both selective 5-HT4 receptor 
agonists, showed that these agents activate the 
cholinergic anti-inflammatory pathway in the  
rodent small intestine. This was suggested to be 
due to activation of 5-HT4 receptors on choliner-
gic myenteric neurons dampening activation of 
resident macrophages. Till now however, even the 
presence of 5-HT4 receptors on cholinergic enteric 
neurons inducing smooth muscle contraction, a 
location established in the pig and human gastro-
intestinal (GI) tract, was not firmly established in 
the murine GI tract. 
2. AIM 
The aim of this study was therefore to investigate 
the influence of prucalopride on submaximal  
cholinergic contractions in different regions of the 
murine GI tract. 
3. METHODS 
Circular smooth muscle strips were prepared from 
the fundus, jejunum and colon (mucosa removed 
for jejunum and colon) and mounted between  
2 stimulation electrodes in an organ bath with  
oxygenated Krebs solution; isometric tension was 
registered. 
For each tissue, electrical field stimulation (EFS) 
was performed with different stimulation para-
meters (voltage, frequency and interstimulus  
interval) to select those parameters inducing  
neurogenic cholinergic on-contractions as checked 
with tetrodotoxin (3 µM) and atropine (1 µM) 
respectively. EFS at these parameters induced 
reproducible contractions; the contraction ampli-
tude was halved by decreasing the voltage (V50%) 
to study the influence of prucalopride (0.003 to  
0.03 µM). The 5-HT4 receptor antagonist, 
GR113808 (0.3 µM), was studied versus 0.03 µM 
prucalopride. 
4. RESULTS 
EFS-induced cholinergic on-contractions were 
obtained in the presence of guanethidine (4 µM) 
and L-NAME (300 µM) to exclude noradrenergic 
and nitrergic influences respectively. Additionally, 
for colon strips the P2Y1 receptor antagonist  
MRS 2500 (1 µM) had to be added to avoid influ-
ences of the relaxant neurotransmitter ATP. EFS 
with 10 s trains (500 µs pulse duration; maximal 
voltage; 4 [fundus] or 8 Hz [jejunum and colon]) at 
5 (fundus and colon) or 10 min (jejunum) interval 
induced reproducible contractions. Upon reduc-
tion of the stimulation voltage to V50%, reproduc-
ible submaximal contractions were obtained; after 
adding prucalopride, contractions by EFS at V50% 
were followed for 50 min. 
Prucalopride concentration-dependently increas-
ed contractions at V50%. The mean contraction 
force (%) 50 minutes after administration of pru-
calopride (0.003, 0.01 and 0.03 µM) was 133, 
181*, 204*** in the fundus; 122*, 124**, 138*** 
 
Acta Gastro-enterologica Belgica - 27th Belgian Week of Gastroenterology, 25-28 February 2015, Brussels, Belgium 
http://www.bwge.be/archives/ 
in the jejunum; 133, 136, 152** in the colon  
(*P < 0.05; **P < 0.01; ***P < 0.001 versus con-
trol; one-way ANOVA with Bonferroni correction; 
n = 6-9). The effect of 0.03 µM prucalopride was 
abolished by the selective 5-HT4 receptor antago-
nist GR113808 (0.3 µM). 
5. CONCLUSION 
These data suggest the presence of 5-HT4 recep-
tors on cholinergic neurons innervating circular 
smooth muscle in murine fundus, jejunum and 
colon. The effective concentrations of pruca-
lopride are lower than those needed at 5-HT4 
receptors in the human and porcine GI tract. 
